This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug 30;120(9):1754-6.

doi: 10.1182/blood-2012-06-434571.

Treating myeloma: the future is already here!

Ola Landgren¹, Neha Korde

Affiliations

PMID: 22936733
DOI: 10.1182/blood-2012-06-434571

Free article

Comment

Treating myeloma: the future is already here!

Ola Landgren et al. Blood. 2012.

Free article

. 2012 Aug 30;120(9):1754-6.

doi: 10.1182/blood-2012-06-434571.

Authors

Ola Landgren¹, Neha Korde

Affiliation

¹ National Cancer Institute, USA.

PMID: 22936733
DOI: 10.1182/blood-2012-06-434571

Erratum in

Blood. 2014 Mar 6;123(10):1621

No abstract available

PubMed Disclaimer

Comment on

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Jakubowiak AJ, Dytfeld D, Griffith KA, Lebovic D, Vesole DH, Jagannath S, Al-Zoubi A, Anderson T, Nordgren B, Detweiler-Short K, Stockerl-Goldstein K, Ahmed A, Jobkar T, Durecki DE, McDonnell K, Mietzel M, Couriel D, Kaminski M, Vij R. Jakubowiak AJ, et al. Blood. 2012 Aug 30;120(9):1801-9. doi: 10.1182/blood-2012-04-422683. Epub 2012 Jun 4. Blood. 2012. PMID: 22665938 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information